| Entry |
|
|---|
| Name |
Dacetuzumab (USAN) |
|---|
| Formula |
C6452H9964N1732O1998S42
|
|---|
| Exact mass |
145019.9592
|
|---|
| Mol weight |
145109.36
|
|---|
| Sequence |
|
|---|
| Type |
Peptide |
|---|
| Efficacy |
Antineoplastic, Anti-CD40 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of CD40-positive cancers
|
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Tumor necrosis factor receptors
TNFRSF5 (CD40)
D08896 Dacetuzumab (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
